Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis

OBJECTIVE: We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA) in a real-world setting. METHODS: Seventy consecutive patients, for whom tofacitinib was initiated between November 2013 and May 2016, were enrolled. All patients fulfilled the 2010 ACR/EULAR cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Naoki, Tsuji, Sosuke, Takatani, Ayuko, Shimizu, Toshimasa, Fukui, Shoichi, Umeda, Masataka, Nishino, Ayako, Horai, Yoshiro, Koga, Tomohiro, Kawashiri, Shin-ya, Aramaki, Toshiyuki, Ichinose, Kunihiro, Hirai, Yasuko, Tamai, Mami, Nakamura, Hideki, Terada, Kaoru, Origuchi, Tomoki, Eguchi, Katsumi, Ueki, Yukitaka, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417647/
https://www.ncbi.nlm.nih.gov/pubmed/28472115
http://dx.doi.org/10.1371/journal.pone.0177057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417647/
https://www.ncbi.nlm.nih.gov/pubmed/28472115
http://dx.doi.org/10.1371/journal.pone.0177057

Ejemplares similares